Tower Research Capital (TRC)’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.3K | Buy |
5,901
+5,834
| +8,707% | +$68.4K | ﹤0.01% | 2586 |
|
|
2025
Q4 | $824 | Sell |
67
-54,615
| -100% | -$547K | ﹤0.01% | 4811 |
|
|
2025
Q3 | $441K | Buy |
54,682
+10,700
| +24% | +$72.5K | 0.01% | 959 |
|
|
2025
Q2 | $227K | Sell |
43,982
-64,739
| -60% | -$336K | 0.01% | 1659 |
|
|
2025
Q1 | $785K | Buy |
+108,721
| New | +$814K | 0.02% | 605 |
|
|
2024
Q4 | – | Sell |
-29,091
| Closed | -$239K | – | 5928 |
|
|
2024
Q3 | $239K | Sell |
29,091
-2,438
| -8% | -$18.3K | 0.01% | 1453 |
|
|
2024
Q2 | $196K | Buy |
+31,529
| New | +$210K | ﹤0.01% | 2086 |
|
|
2024
Q1 | – | Sell |
-33,769
| Closed | -$262K | – | 6072 |
|
|
2023
Q4 | $262K | Buy |
+33,769
| New | +$203K | ﹤0.01% | 1879 |
|
|
2023
Q2 | – | Sell |
-5,210
| Closed | -$45K | – | 6287 |
|
|
2023
Q1 | $45K | Sell |
5,210
-8,672
| -62% | -$82K | ﹤0.01% | 2592 |
|
|
2022
Q4 | $125K | Buy |
13,882
+6,195
| +81% | +$59.6K | 0.01% | 1658 |
|
|
2022
Q3 | $68K | Sell |
7,687
-30,410
| -80% | -$337K | ﹤0.01% | 2886 |
|
|
2022
Q2 | $412K | Sell |
38,097
-8,539
| -18% | -$95.6K | 0.01% | 1259 |
|
|
2022
Q1 | $675K | Buy |
46,636
+17,881
| +62% | +$241K | 0.01% | 981 |
|
|
2021
Q4 | $457K | Buy |
+28,755
| New | +$502K | 0.01% | 1173 |
|
|
2021
Q3 | – | Sell |
-10,562
| Closed | -$250K | – | 6067 |
|
|
2021
Q2 | $250K | Buy |
+10,562
| New | +$230K | 0.01% | 1756 |
|
|
2020
Q3 | – | Sell |
-31,856
| Closed | -$491K | – | 5035 |
|
|
2020
Q2 | $491K | Buy |
+31,856
| New | +$449K | 0.02% | 1056 |
|
|
2020
Q1 | – | Sell |
-17,084
| Closed | -$432K | – | 3690 |
|
|
2019
Q4 | $432K | Buy |
17,084
+1,643
| +11% | +$28K | 0.04% | 306 |
|
|
2019
Q3 | $192K | Buy |
15,441
+13,421
| +664% | +$196K | 0.01% | 1027 |
|
|
2019
Q2 | $36K | Buy |
+2,020
| New | +$39.4K | ﹤0.01% | 1800 |
|
Other funds holding PILL
Tower Research Capital (TRC)'s PILL Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) stake by 8,707% in Q1 2026, buying an estimated $68.4K and bringing the position to 5,901 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2586.
Tower Research Capital (TRC) first reported a position in PILL in Q2 2019 and has held it in 19 quarters since. The position peaked at $785K in Q1 2025. 5 funds tracked by Wall St. Rank hold PILL as of Q1 2026.
- Tower Research Capital (TRC) held 5,901 shares of Direxion Daily Pharmaceutical & Medical Bull 3X ETF worth $60.3K as of Q1 2026.
- Tower Research Capital (TRC) bought 5,834 Direxion Daily Pharmaceutical & Medical Bull 3X ETF shares in Q1 2026, an estimated $68.4K.
- Direxion Daily Pharmaceutical & Medical Bull 3X ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2586 holding.
- Tower Research Capital (TRC) first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q2 2019 and has held it in 19 quarters since.
- Tower Research Capital (TRC)'s Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $785K in Q1 2025.
- 5 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.